Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

MannKind Corporation - Common Stock (NQ:MNKD)

2.610 -0.220 (-7.77%)

Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	9,375,219
Open	2.810
Bid (Size)	2.620 (4,100)
Ask (Size)	2.640 (300)
Prev. Close	2.830
Today's Range	2.585 - 2.810
52wk Range	2.810 - 6.510
Shares Outstanding	264,305,532
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

MannKind Announces Settlement of Convertible Senior Notes

March 05, 2026

From MannKind

Via GlobeNewswire

MannKind to Participate in Upcoming Investor Conferences

March 04, 2026

From MannKind

Via GlobeNewswire

Performance

YTD	-53.4%	-53.4%
1 Month	-58.0%	-58.0%
3 Month	-54.3%	-54.3%
6 Month	-51.1%	-51.1%
1 Year	-49.3%	-49.3%

More News

What's Going On With MannKind Stock Friday? ↗

February 27, 2026

Via Benzinga

Why MannKind Stock Tumbled on Thursday ↗

February 26, 2026

Via The Motley Fool

MannKind Corp (NASDAQ:MNKD) Reports Q4 2025 Revenue Beat and Strategic Outlook for 2026 ↗

February 26, 2026

Via Chartmill

MannKind Rallies On Optimism Of Two Imminent Product Launches: Analyst Sees ‘Multiple Headwinds’ For Stock In 2026 ↗

January 08, 2026

Via Stocktwits

MannKind Stock Slips Despite FDA Clearing Pediatric Use Of Heart Failure Drug — What’s Spooking Investors? ↗

December 23, 2025

Via Stocktwits

MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

February 26, 2026

From MannKind

Via GlobeNewswire

Let's take a look at the stocks that are in motion in today's session. ↗

February 25, 2026

Via Chartmill

MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ ↗

February 25, 2026

Via Stocktwits

Here are the top movers in Wednesday's session. ↗

February 25, 2026

Via Chartmill

The market is filled with gapping stocks in Wednesday's session. ↗

February 25, 2026

Via Chartmill

MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 19, 2026

From MannKind

Via GlobeNewswire

MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

February 18, 2026

From MannKind

Via GlobeNewswire

MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)

February 09, 2026

From MannKind

Via GlobeNewswire

Why Did MNKD Stock Jump Over 7% In Pre-Market Today? ↗

January 26, 2026

Via Stocktwits

MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy

January 26, 2026

From MannKind

Via GlobeNewswire

Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets

January 23, 2026

From Equity Insider

Via GlobeNewswire

MannKind Provides Business Updates and 2026 Growth Drivers

January 08, 2026

From MannKind

Via GlobeNewswire

Is MannKind Stock a Buy or Sell After the CEO Sold Nearly 66,000 Shares? ↗

December 24, 2025

Via The Motley Fool

Why a Fund Trimmed an $18 Million Stake in Primo Brands Amid a 47% Stock Drop ↗

December 23, 2025

Via The Motley Fool

Lantheus Exit: $28 Million Sale Comes as Earnings Fall 77% Year Over Year ↗

December 23, 2025

Via The Motley Fool

MannKind Shares FUROSCIX® Business Updates

December 23, 2025

From MannKind

Via GlobeNewswire

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease

December 01, 2025

From MannKind

Via GlobeNewswire

MannKind to Present at the Jefferies Global Healthcare Conference

November 11, 2025

From MannKind

Via GlobeNewswire

Frequently Asked Questions

Is MannKind Corporation - Common Stock publicly traded?

Yes, MannKind Corporation - Common Stock is publicly traded.

What exchange does MannKind Corporation - Common Stock trade on?

MannKind Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for MannKind Corporation - Common Stock?

The ticker symbol for MannKind Corporation - Common Stock is MNKD on the Nasdaq Stock Market

What is the current price of MannKind Corporation - Common Stock?

The current price of MannKind Corporation - Common Stock is 2.610

When was MannKind Corporation - Common Stock last traded?

The last trade of MannKind Corporation - Common Stock was at 03/06/26 04:00 PM ET

What is the market capitalization of MannKind Corporation - Common Stock?

The market capitalization of MannKind Corporation - Common Stock is 689.84M

How many shares of MannKind Corporation - Common Stock are outstanding?

MannKind Corporation - Common Stock has 690M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.